Position in HIMS
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$541,857
+$223,108 QoQ
Shares Held
15,629
+1.8% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#262
of 504 holders
Holding Since
Mar 2025
6 quarters on record
Common Shares in HIMS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026SECURIAN ASSET MANAGEMENT, INC holds $6,215,673 across 7 Drug Manufacturers - Specialty & Generic names. HIMS ranks #5 (8.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
3,130 | $1,695,927 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
7,398 | $1,246,858 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
36,832 | $906,435 | |
| 4 | ZTS |
Zoetis Inc.
|
11,140 | $800,520 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
This page
|
15,629 | $541,857 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
4,801 | $532,622 | |
| 7 | VTRS |
Viatris Inc
|
30,948 | $491,454 |
All Filings in HIMS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $541,857 | 15,629 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $318,749 | 15,354 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $491,011 | 15,122 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $878,309 | 15,485 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $744,310 | 14,931 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $429,066 | 14,520 | Shares | Sole | 2025-05-01 | |
| No filing history on record for this holder in this stock. | ||||||